Retinopathy of prematurity in the time of bevacizumab: incorporating the BEAT-ROP results into clinical practice. [electronic resource]
Producer: 20110905Description: 1227-8 p. digitalISSN:- 1549-4713
- Angiogenesis Inhibitors -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Bevacizumab
- Clinical Trials, Phase II as Topic
- Diffusion of Innovation
- Humans
- Infant, Newborn
- Multicenter Studies as Topic
- Neovascularization, Pathologic -- etiology
- Prospective Studies
- Randomized Controlled Trials as Topic
- Retinopathy of Prematurity -- complications
No physical items for this record
Publication Type: Editorial
There are no comments on this title.
Log in to your account to post a comment.